March 16, 2022
Feyi Olopade Ayodele and Olufunmilayo Olopade, MD.
(PHOTO: BUSINESS WIRE)
Stories this photo appears in:
CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention
CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), as well as CancerIQ’s Series A lead investor, HealthX Ventures, also participated in the Series B round